is yet more proof that this is an area on the cusp of the pharmaceutical R&D mainstream. That was one of the key messages from SynBioBeta’s Synthetic Biology Biopharma Conference last month ...

set up a pharmaceutical business in 1876. He was a pioneer of new methods in the industry, being one of the first to focus on R&D as well as manufacturing. Another military man in the drugs ...

R&D leaders grapple with decisions about programme ... For a typical portfolio of a leading pharmaceutical company, assuming a composition of 75% small molecules and 25% biologics distributed ...

In the 20th century, pharmaceutical manufacturers made massive R&D investments in a collective quest to discover the next generation of lifesaving medications. Among those innovations were birth ...

Union Finance Minister Nirmala Sitharaman is all set to present the Budget for the financial year 2025-26 in parliament on ...

a role responsible for overseeing the drugmaker's R&D efforts. Boshoff, who has headed the New York-based pharma giant's cancer research and marketing for over a year as Chief Oncology Officer ...

Pharmaceutical and hospital sector executives are requesting higher public healthcare spending, R&D incentives, and tax ...

That’s according to the Deloitte U.S. Center for Health Solutions, which found in a recent survey of 150 C-suite executives across the global life sciences sphere that 75% of respondents are ...

“With the expansion of R&D and the integration of CMS expertise, we can rapidly advance our product offerings to meet the high demands of the pharmaceutical industry,” said Wayne ...